Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

  • STATUS
    Not Recruiting
  • End date
    May 5, 2023
  • participants needed
    1000
  • sponsor
    Concert Pharmaceuticals
Updated on 13 June 2022
alopecia
areata alopecia

Summary

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.

Details
Condition Alopecia Areata
Treatment CTP-543
Clinical Study IdentifierNCT03898479
SponsorConcert Pharmaceuticals
Last Modified on13 June 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note